2020
DOI: 10.1016/j.gastre.2020.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Effect on the adherence to concomitant medications after initiation of treatment with direct-acting antiviral agents against hepatitis C virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…The choice of SVR12 in the present study instead of a 24‐week interval from anti‐HCV treatment start may justify the different result and reinforce our hypothesis even though we cannot exclude that some patients could have a detectable but not quantifiable HIV‐RNA if retested. However, a higher adherence to ART during DAA treatment should be taken into account as well 20 . We are aware that only slight differences in viroimmunological parameters were reported but, on the other hand, the patients included were immunocompetent and with an ongoing antiretroviral treatment, even if with a different level of virological suppression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The choice of SVR12 in the present study instead of a 24‐week interval from anti‐HCV treatment start may justify the different result and reinforce our hypothesis even though we cannot exclude that some patients could have a detectable but not quantifiable HIV‐RNA if retested. However, a higher adherence to ART during DAA treatment should be taken into account as well 20 . We are aware that only slight differences in viroimmunological parameters were reported but, on the other hand, the patients included were immunocompetent and with an ongoing antiretroviral treatment, even if with a different level of virological suppression.…”
Section: Discussionmentioning
confidence: 99%
“…However, a higher adherence to ART during DAA treatment should be taken into account as well. 20 We are aware that only slight differences in viroimmunological parameters were reported but, on the other hand, the patients included were immunocompetent and with an ongoing antiretroviral treatment, even if with a different level of virological suppression.…”
Section: Methodsmentioning
confidence: 99%